Differences in glutamate-mediated plasticity mechanisms are also noted in mouse models of CDD, where expression of AMPARs lacking the GluA2 subunit is increased [37] (Figure 1). This evidence concerns the gene GRIA2 and craniodiaphyseal dysplasia.